(ECMPA) Eurocommercial Properties - Ratings and Ratios
Shopping Centres, Retail, Real Estate
Dividends
| Dividend Yield | 7.05% |
| Yield on Cost 5y | 16.57% |
| Yield CAGR 5y | 50.37% |
| Payout Consistency | 90.0% |
| Payout Ratio | 61.5% |
| Risk via 10d forecast | |
|---|---|
| Volatility | 18.2% |
| Value at Risk 5%th | 29.8% |
| Relative Tail Risk | -0.55% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.99 |
| Alpha | 17.98 |
| CAGR/Max DD | 0.64 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.441 |
| Beta | 0.024 |
| Beta Downside | 0.113 |
| Drawdowns 3y | |
|---|---|
| Max DD | 15.87% |
| Mean DD | 5.38% |
| Median DD | 4.69% |
Description: ECMPA Eurocommercial Properties November 12, 2025
Eurocommercial Properties N.V. (ticker ECMPA) is a Netherlands-based, Euronext-listed REIT that focuses on shopping-centre assets across Belgium, France, Italy and Sweden. Since its founding in 1991, the company has built a portfolio of 24 centres valued at roughly €4 billion, positioning it as one of Europe’s leading retail-property specialists.
Key operating metrics that investors watch include an average occupancy rate of ~93 % (Q2 2024) and a net operating income (NOI) growth of 5 % year-over-year, driven by a mix of “experience-focused” tenants and gradual rent-up-steps. The sector remains sensitive to macro-drivers such as consumer confidence, disposable-income trends, and the ongoing shift toward omnichannel retail, which has been moderating foot-traffic growth in some markets while rewarding centres that integrate leisure and services.
For a deeper, data-driven view of Eurocommercial’s valuation dynamics and scenario analysis, you may find it worthwhile to explore the company’s profile on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 2.5
| Net Income (129.2m TTM) > 0 and > 6% of Revenue (6% = 15.9m TTM) |
| FCFTA 0.02 (>2.0%) and ΔFCFTA -0.11pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -51.09% (prev -181.1%; Δ 130.0pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.02 (>3.0%) and CFO 97.0m <= Net Income 129.2m (YES >=105%, WARN >=100%) |
| Net Debt (1.53b) to EBITDA (174.5m) ratio: 8.75 <= 3.0 (WARN <= 3.5) |
| Current Ratio 0.48 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (53.8m) change vs 12m ago 0.64% (target <= -2.0% for YES) |
| Gross Margin 79.34% (prev 64.36%; Δ 14.98pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 6.72% (prev 6.74%; Δ -0.01pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 3.24 (EBITDA TTM 174.5m / Interest Expense TTM 53.2m) >= 6 (WARN >= 3) |
Altman Z'' 0.13
| (A) -0.03 = (Total Current Assets 125.1m - Total Current Liabilities 260.8m) / Total Assets 4.04b |
| (B) 0.01 = Retained Earnings (Balance) 42.3m / Total Assets 4.04b |
| (C) 0.04 = EBIT TTM 172.4m / Avg Total Assets 3.95b |
| (D) 0.02 = Book Value of Equity 42.3m / Total Liabilities 1.97b |
| Total Rating: 0.13 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 56.68
| 1. Piotroski 2.50pt |
| 2. FCF Yield 2.20% |
| 3. FCF Margin 24.23% |
| 4. Debt/Equity 0.77 |
| 5. Debt/Ebitda 8.75 |
| 6. ROIC - WACC (= -2.45)% |
| 7. RoE 6.24% |
| 8. Rev. Trend 74.16% |
| 9. EPS Trend -14.33% |
What is the price of ECMPA shares?
Over the past week, the price has changed by -2.29%, over one month by -3.40%, over three months by -1.54% and over the past year by +21.34%.
Is ECMPA a buy, sell or hold?
What are the forecasts/targets for the ECMPA price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 29.3 | 14.8% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 31 | 21.3% |
ECMPA Fundamental Data Overview December 12, 2025
Market Cap EUR = 1.40b (1.40b EUR * 1.0 EUR.EUR)
P/E Trailing = 8.7842
P/E Forward = 10.4058
P/S = 5.0
P/B = 0.6684
Beta = 0.86
Revenue TTM = 265.7m EUR
EBIT TTM = 172.4m EUR
EBITDA TTM = 174.5m EUR
Long Term Debt = 1.47b EUR (from longTermDebt, last quarter)
Short Term Debt = 113.7m EUR (from shortLongTermDebt, last quarter)
Debt = 1.59b EUR (Calculated: Short Term 113.7m + Long Term 1.47b)
Net Debt = 1.53b EUR (from netDebt column, last quarter)
Enterprise Value = 2.92b EUR (1.40b + Debt 1.59b - CCE 61.1m)
Interest Coverage Ratio = 3.24 (Ebit TTM 172.4m / Interest Expense TTM 53.2m)
FCF Yield = 2.20% (FCF TTM 64.4m / Enterprise Value 2.92b)
FCF Margin = 24.23% (FCF TTM 64.4m / Revenue TTM 265.7m)
Net Margin = 48.64% (Net Income TTM 129.2m / Revenue TTM 265.7m)
Gross Margin = 79.34% ((Revenue TTM 265.7m - Cost of Revenue TTM 54.9m) / Revenue TTM)
Gross Margin QoQ = 71.57% (prev 71.42%)
Tobins Q-Ratio = 0.72 (Enterprise Value 2.92b / Total Assets 4.04b)
Interest Expense / Debt = 0.83% (Interest Expense 13.2m / Debt 1.59b)
Taxrate = 90.55% (64.6m / 71.4m)
NOPAT = 16.3m (EBIT 172.4m * (1 - 90.55%))
Current Ratio = 0.48 (Total Current Assets 125.1m / Total Current Liabilities 260.8m)
Debt / Equity = 0.77 (Debt 1.59b / totalStockholderEquity, last quarter 2.07b)
Debt / EBITDA = 8.75 (Net Debt 1.53b / EBITDA 174.5m)
Debt / FCF = 23.73 (Net Debt 1.53b / FCF TTM 64.4m)
Total Stockholder Equity = 2.07b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.20% (Net Income 129.2m / Total Assets 4.04b)
RoE = 6.24% (Net Income TTM 129.2m / Total Stockholder Equity 2.07b)
RoCE = 4.87% (EBIT 172.4m / Capital Employed (Equity 2.07b + L.T.Debt 1.47b))
RoIC = 0.45% (NOPAT 16.3m / Invested Capital 3.64b)
WACC = 2.89% (E(1.40b)/V(2.98b) * Re(6.10%) + D(1.59b)/V(2.98b) * Rd(0.83%) * (1-Tc(0.91)))
Discount Rate = 6.10% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: 100.0 | Cagr: 3.15%
[DCF Debug] Terminal Value 77.50% ; FCFE base≈65.0m ; Y1≈61.6m ; Y5≈58.9m
Fair Price DCF = 19.34 (DCF Value 1.05b / Shares Outstanding 54.4m; 5y FCF grow -6.65% → 3.0% )
EPS Correlation: -14.33 | EPS CAGR: 4.06% | SUE: 1.00 | # QB: 1
Revenue Correlation: 74.16 | Revenue CAGR: 4.82% | SUE: 4.0 | # QB: 8
EPS next Year (2026-12-31): EPS=2.46 | Chg30d=-0.005 | Revisions Net=-1 | Growth EPS=+2.2% | Growth Revenue=+1.7%